NCT05878405 2025-04-30
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
Mayo Clinic
Phase 3 Completed
Clinical Trials
10 trialsNCT03237325 2022-11-08
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Soligenix
Phase 3 Completed
NCT00293462 2021-07-30
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
University of California, San Francisco
Phase 3 Completed
NCT01265810 2017-11-13
COMTT
Impaqtt Foundation
Phase 3 Completed
NCT00131638 2016-12-16
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer
Amgen
Phase 3 Completed
NCT00101582 2016-09-27
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Swedish Orphan Biovitrum
Phase 3 Completed
NCT02555501 2015-09-21
OMLTPT
Universidade Ceuma
Phase 3 Completed
NCT01439724 2014-04-11
Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients
Instituto Nacional de Cancer, Brazil
Phase 3 Completed
NCT00051441 2011-05-19
Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 3 Completed
NCT00790322 2010-02-19
Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy
Biotec Pharmacon ASA
Phase 3 Completed